Thorsten Fuereder

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 9

Top Topics

Brain Metastases

Squamous Cell Carcinoma

Top Venues

Medical oncology (Northwood, London, England)

Clinical & experimental metastasis

International journal of molecular sciences

This page only lists publications with an associated author ORCID identifier.

Publications

Markus Haas, Alexander Lein, Thorsten Fuereder, Faris F Brkic, Julia Schnöll, David Tianxiang Liu, Lorenz Kadletz-Wanke, Gregor Heiduschka, Bernhard J Jank
The Geriatric Nutritional Risk Index (GNRI) as a Prognostic Biomarker for Immune Checkpoint Inhibitor Response in Recurrent and/or Metastatic Head and Neck Cancer. Nutrients 15 (4) (2023)
Markus Haas, Alexander Lein, Thorsten Fuereder, Faris F Brkic, Julia Schnöll, David Tianxiang Liu, Lorenz Kadletz-Wanke, Gregor Heiduschka, Bernhard J Jank
The Geriatric Nutritional Risk Index (GNRI) as a Prognostic Biomarker for Immune Checkpoint Inhibitor Response in Recurrent and/or Metastatic Head and Neck Cancer. Nutrients 15 (4) (2023)
Petar Popov, Ariane Steindl, Ladislaia Wolff, Elisabeth S Bergen, Franziska Eckert, Josa Maria Frischer, Georg Widhalm, Thorsten Fuereder, Markus Raderer, Anna Sophie Berghoff, Matthias Preusser, Barbara Kiesewetter
Clinical characteristics, treatment, and outcome of patients with large cell neuroendocrine carcinoma of the lung and brain metastases - data from a tertiary care center. Clinical & experimental metastasis (2023)
Markus Haas, Alexander Lein, Thorsten Fuereder, Faris F Brkic, Julia Schnöll, David Tianxiang Liu, Lorenz Kadletz-Wanke, Gregor Heiduschka, Bernhard J Jank
The Geriatric Nutritional Risk Index (GNRI) as a Prognostic Biomarker for Immune Checkpoint Inhibitor Response in Recurrent and/or Metastatic Head and Neck Cancer. Nutrients 15 (4) (2023)
Markus Haas, Alexander Lein, Thorsten Fuereder, Faris F Brkic, Julia Schnöll, David Tianxiang Liu, Lorenz Kadletz-Wanke, Gregor Heiduschka, Bernhard J Jank
The Geriatric Nutritional Risk Index (GNRI) as a Prognostic Biomarker for Immune Checkpoint Inhibitor Response in Recurrent and/or Metastatic Head and Neck Cancer. Nutrients 15 (4) (2023)
Markus Haas, Alexander Lein, Thorsten Fuereder, Faris F Brkic, Julia Schnöll, David Tianxiang Liu, Lorenz Kadletz-Wanke, Gregor Heiduschka, Bernhard J Jank
The Geriatric Nutritional Risk Index (GNRI) as a Prognostic Biomarker for Immune Checkpoint Inhibitor Response in Recurrent and/or Metastatic Head and Neck Cancer. Nutrients 15 (4) (2023)
Alexander Michael Grandits, Sophie Bromberger, Gerwin Heller, Barbara Andrea Reinoehl, Erwin Tomasich, Klaudia Schossleitner, Anna Sophie Berghoff, Thorsten Fuereder, Rotraud Wieser
EVI1 Promotes the Proliferation and Invasive Properties of Human Head and Neck Squamous Cell Carcinoma Cells. International journal of molecular sciences 23 (3) (2022)
Thomas Bartl, Arina Onoprienko, Gerda Hofstetter, Leonhard Müllauer, Nina Poetsch, Thorsten Fuereder, Paul Kofler, Stephan Polterauer, Christoph Grimm
Overweight as a Favorable Clinical Biomarker for Checkpoint Inhibitor Therapy Response in Recurrent Gynecologic Cancer Patients. Biomolecules 11 (11) (2021)
Hannah Fuchs, Johannes Pammer, Christoph Minichsdorfer, Doris Posch, Gabriela Kornek, Marie-Bernadette Aretin, Thorsten Fuereder
Modified biweekly cisplatin, docetaxel plus cetuximab (TPEx) as first-line treatment for patients with recurrent/metastatic head and neck cancer. Medical oncology (Northwood, London, England) 35 (3) (2018)